Trulance® Safety Approved for adult patients with CIC and IBS-C. ISI below.
Trulance Overview CIC Indication IBS-C Indication Patient Support HCP Resources Investors
Contact HCP Portal
Home/Trulance for CIC

TRULANCE® for CIC

For adult patients with chronic idiopathic constipation

Review indication details, safety considerations, and resources that support appropriate use of TRULANCE in CIC.

HCP resources Patient education

Indication

TRULANCE is indicated for treatment of adults with CIC

Safety and efficacy have not been established in patients under 18 years of age. TRULANCE is contraindicated in patients less than 6 years of age due to risk of serious dehydration.

Patient in clinical setting
  • Evaluate patients for potential mechanical GI obstruction prior to initiation.
  • Discuss the possibility of diarrhea—the most common adverse reaction—and advise when to contact a healthcare professional.
  • Reinforce adherence and align expectations on therapy onset and follow-up.
Access & support Clinical data →
Clinical reminder: If severe diarrhea occurs, suspend dosing and contact a healthcare provider. Always review Important Safety Information with patients starting TRULANCE.